Kingfa Science & Technology (India) Share Price & Earnings Call Analysis
- Market cap
- ₹9,062 Cr
- P/E
- 40.15
- ROE
- 17.41%
- PEG
- 1.27
- Price to sales
- 4.08
- Debt to equity
- 0.01
- 52W high / low
- ₹6,932 / ₹3,759
- Sales growth (5Y)
- 26.05%
- EBITDA margin
- 14.15%
- Net profit margin
- 9.28%
- Promoter holding
- 67.02%
- Sales (last year)
- ₹2,222 Cr
Kingfa Science & Technology (India) Limited, a subsidiary company of M/s Kingfa Science & Technology Co. Ltd China, is engaged in the business of manufacturing and supply of high-quality modified plastic compounds for automotive and consumer products and personal protective equipments like masks and gloves. [1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Industrial Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹448 Cr | 17.9 | |
| 2 | 40%+ | Up 2%+ | ₹413 Cr | 12.0 | |
| 3 | 40%+ | Up 2%+ | ₹324 Cr | 22.7 | |
| 4 | 40%+ | Up 0–2% | ₹1,496 Cr | 32.8 | |
| 5 | 40%+ | Up 0–2% | ₹1,079 Cr | 12.7 | |
| 6 | 40%+ | Flat | ₹827 Cr | 21.4 |
Sign up free to see every company in the sector ranking and track Kingfa Science.
Pro shows every company guiding 40%+ revenue growth →Full Industrial Products rankingFinancials of Kingfa Science
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Kingfa Science
Quarterly Results
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 340 | 366 | 339 | 351 | 394 | 404 | 416 | 418 | 440 | 470 | 462 | 466 | 489 |
| Expenses + | 310 | 311 | 289 | 306 | 356 | 354 | 359 | 362 | 389 | 409 | 404 | 405 | 428 |
| Operating Profit | 31 | 55 | 50 | 45 | 38 | 51 | 57 | 56 | 51 | 60 | 58 | 61 | 62 |
| OPM % | 9% | 15% | 15% | 13% | 10% | 13% | 14% | 13% | 12% | 13% | 13% | 13% | 13% |
| Other Income + | 1 | 1 | 2 | 0 | 1 | 2 | 2 | 1 | 5 | 2 | 4 | 3 | 7 |
| Interest | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 |
| Profit before tax | 27 | 49 | 47 | 40 | 32 | 45 | 52 | 50 | 49 | 54 | 54 | 55 | 61 |
| Tax % | 25% | 26% | 25% | 25% | 25% | 26% | 25% | 26% | 30% | 23% | 26% | 26% | 26% |
| Net Profit + | 20 | 37 | 35 | 30 | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 |
| EPS in Rs | 16.70 | 30.24 | 28.93 | 24.44 | 20.09 | 27.70 | 32.26 | 30.77 | 28.60 | 34.60 | 32.86 | 30.36 | 33.33 |
Financials of Kingfa Science
Profit & Loss
Annual income statement trend
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 178 | 219 | 314 | 427 | 602 | 702 | 742 | 627 | 1,048 | 1,404 | 1,488 | 1,745 | 1,887 |
| Expenses + | 181 | 212 | 288 | 408 | 560 | 666 | 698 | 607 | 966 | 1,276 | 1,303 | 1,520 | 1,646 |
| Operating Profit | -3 | 6 | 27 | 19 | 41 | 35 | 43 | 20 | 82 | 128 | 185 | 225 | 241 |
| OPM % | -2% | 3% | 8% | 5% | 7% | 5% | 6% | 3% | 8% | 9% | 12% | 13% | 13% |
| Other Income + | 0 | 0 | 1 | 4 | 6 | 4 | 3 | 6 | -22 | 2 | 3 | 9 | 15 |
| Interest | 7 | 8 | 7 | 2 | 2 | 2 | 4 | 3 | 5 | 7 | 6 | 7 | 5 |
| Depreciation | 3 | 3 | 3 | 3 | 6 | 8 | 9 | 11 | 13 | 14 | 18 | 22 | 26 |
| Profit before tax | -12 | -5 | 17 | 18 | 39 | 29 | 33 | 12 | 41 | 110 | 164 | 206 | 224 |
| Tax % | -31% | -35% | 38% | 30% | 36% | 35% | 26% | 55% | 26% | 26% | 25% | 26% | |
| Net Profit + | -8 | -3 | 11 | 12 | 25 | 19 | 25 | 5 | 31 | 81 | 123 | 153 | 168 |
| EPS in Rs | -6.95 | -2.49 | 8.93 | 10.24 | 20.35 | 15.74 | 20.33 | 4.39 | 25.29 | 67.22 | 101.17 | 126.22 | 131.15 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% |
Financials of Kingfa Science
Balance Sheet
Capital structure and asset base
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 10 | 10 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 14 |
| Reserves | 5 | 2 | 109 | 234 | 293 | 312 | 336 | 342 | 372 | 454 | 576 | 716 | 1,281 |
| Borrowings + | 62 | 75 | 16 | 42 | 21 | 17 | 46 | 71 | 46 | 42 | 33 | 43 | 19 |
| Other Liabilities + | 31 | 41 | 95 | 119 | 159 | 210 | 202 | 246 | 449 | 502 | 373 | 384 | 421 |
| Total Liabilities | 105 | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,156 | 1,735 |
| Fixed Assets + | 24 | 25 | 29 | 76 | 88 | 85 | 107 | 129 | 126 | 123 | 252 | 244 | 290 |
| CWIP | 0 | 1 | 41 | 10 | 2 | 79 | 115 | 123 | 127 | 131 | 2 | 41 | 45 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 81 | 99 | 160 | 319 | 395 | 388 | 375 | 419 | 627 | 756 | 740 | 871 | 1,399 |
| Total Assets | 105 | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,156 | 1,735 |
Financials of Kingfa Science
Cash Flows
Operating, investing and financing cash movement
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -24 | -1 | 19 | -119 | -116 | 96 | 30 | -2 | 38 | 27 | 16 | 60 |
| Cash from Investing Activity + | -1 | -4 | -47 | -18 | -6 | -77 | -63 | -14 | -19 | -12 | 2 | -30 |
| Cash from Financing Activity + | 25 | 5 | 34 | 137 | 14 | -7 | 22 | 17 | -14 | -21 | -8 | -7 |
| Net Cash Flow | 0 | 0 | 6 | -1 | -108 | 12 | -11 | 1 | 5 | -6 | 10 | 23 |
| Free Cash Flow | -26 | -5 | -28 | -138 | -127 | 14 | -35 | -17 | 19 | 3 | -5 | 30 |
| CFO/OP | 741% | -13% | 72% | -602% | -256% | 300% | 111% | 5% | 63% | 35% | 29% | 56% |
Financials of Kingfa Science
Ratios
Working capital efficiency and return ratios
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 97 | 93 | 99 | 111 | 110 | 109 | 97 | 123 | 99 | 93 | 99 | 93 |
| Inventory Days | 54 | 64 | 85 | 69 | 85 | 63 | 67 | 100 | 110 | 94 | 76 | 82 |
| Days Payable | 66 | 72 | 127 | 108 | 108 | 119 | 115 | 152 | 181 | 155 | 110 | 94 |
| Cash Conversion Cycle | 85 | 85 | 57 | 72 | 86 | 53 | 49 | 71 | 28 | 32 | 66 | 80 |
| Working Capital Days | -7 | -14 | 66 | 59 | 96 | 59 | 55 | 57 | 39 | 45 | 78 | 85 |
| ROCE % | -9% | 4% | 22% | 9% | 13% | 9% | 10% | 4% | 16% | 25% | 30% | 31% |
Momentum score · price trend
87 out of 100 — Strengthening
Over the past year its share price has done better than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +43.9% | 84% |
| Last 6 months | +41.3% | 87% |
| Last 3 months | +29.0% | 92% |
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Kingfa Science: 0.4 × 84 + 0.4 × 87 + 0.2 × 92 = 87.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
Others in Industrial Products this season
- Graphite India (Q2 FY27)
826 Crores, up 13.3% year-on-year (YoY) (Page 4, 9, 14) . Key investor presentation takeaways from Graphite India Ltd's Q2 FY27 investor presentation — and how
- Harsha Engineers International Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: ₹44,009 lakhs, up 16.3% YoY from ₹37,834 lakhs in Q2 FY26 (Page 7, 9). Key investor presentation takeaways from Ha
- AIA Engineering Ltd (Q2 FY27)
63,159 in Q2 FY 2025-26 (down ~2.6%) . Key investor presentation takeaways from AIA Engineering Ltd's Q2 FY27 investor presentation — and how it ranks against s
- Synergy Green (Q2 FY27)
Q2 FY27 Total Income: Rs 75.71 crore, compared to Rs 74.37 crore in Q2 FY26 (approximately flat YoY). Key investor presentation takeaways from Synergy Green Ind
